Furthermore, research in mouse models has demonstrated that the combined treatment of sympathetic nerves and CTLA-4 blockers significantly suppressed tumor growth and enhanced the infiltration of CD8+ T cells at the tumor site (48). This evidence concerns the gene CTLA4 and neoplasm.